Profilo
R.
Michael Floyd was the founder of Elion Oncology, Inc., founded in 2016, and held the titles of President, Chief Executive Officer & Director at the company.
Mr. Floyd is also the founder of BioAim LLC,Exbaq LLC..
Mr. Floyd was Chief Executive Officer-North America at EvoNext Holdings SA. Mr. Floyd was Chief Operating Officer at Processa Pharmaceuticals, Inc. from 2020 to 2023.
Mr. Floyd completed undergraduate education at Georgetown University.
Precedenti posizioni note di R. Floyd
| Società | Posizione | Fine |
|---|---|---|
| PROCESSA PHARMACEUTICALS, INC. | Direttore operativo | 31/08/2023 |
BioAim LLC | Fondatore | - |
Exbaq LLC | Fondatore | - |
| EVONEXT HOLDINGS SA | Corporate Officer/Principal | - |
Elion Oncology, Inc.
Elion Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology related biopharmaceutical products | Fondatore | - |
Formazione di R. Floyd
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 6 |
|---|---|
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Evolva Holding SA
Evolva Holding SA Food: Specialty/CandyConsumer Non-Durables Develops and sells flavors, fragrances and health ingredients | Consumer Non-Durables |
Processa Pharmaceuticals, Inc.
Processa Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drug products | Health Technology |
Elion Oncology, Inc.
Elion Oncology, Inc. Pharmaceuticals: MajorHealth Technology Manufactures oncology related biopharmaceutical products | Health Technology |
BioAim LLC | |
Exbaq LLC |
















